D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism

被引:161
作者
Bolan, Elizabeth A.
Kivell, Bronwyn
Jaligam, Vanaja
Oz, Murat
Jayanthi, Lankupalle D.
Han, Yang
Sen, Namita
Urizar, Eneki
Gomes, Ivone
Devi, Lakshmi A.
Ramamoorthy, Sammanda
Javitch, Jonathan A.
Zapata, Agustin
Shippenberg, Toni S.
机构
[1] NIDA, IRP, DHHS,Integrat Neurosci Sect, NIH, Baltimore, MD 21224 USA
[2] Med Univ S Carolina, Div Neurosci Res, Dept Neurosci, Charleston, SC 29425 USA
[3] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY USA
[4] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA
[5] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA
[6] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY USA
关键词
D O I
10.1124/mol.106.027763
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The dopamine transporter (DAT) terminates dopamine (DA) neurotransmission by reuptake of DA into presynaptic neurons. Regulation of DA uptake by D-2 dopamine receptors (D-2 R) has been reported. The high affinity of DA and other DAT substrates for the D2R, however, has complicated investigation of the intracellular mechanisms mediating this effect. The present studies used the fluorescent DAT substrate, 4-[4-(diethylamino)styryl]- N-methylpyridinium iodide (ASP(+)) with live cell imaging techniques to identify the role of two D2R-linked signaling pathways, extracellular signal-regulated kinases 1 and 2 (ERK1/2), and phosphoinositide 3 kinase (PI3K) in mediating D2R regulation of DAT. Addition of the D-2/D-3 receptor agonist quinpirole (0.1 - 10 mu M) to human embryonic kidney cells coexpressing human DAT and D-2 receptor ( short splice variant, D2SR) induced a rapid, concentration-dependent and pertussis toxin-sensitive increase in ASP(+) accumulation. The D-2/D-3 agonist (S)-(+)-(4aR, 10bR)-3,4,4a, 10b-tetrahydro-4-propyl-2H, 5H-[1] benzopyrano-[4,3-b]-1,4-oxazin-9-ol hydrochloride (PD128907) also increased ASP(+) accumulation. D2SR activation increased phosphorylation of ERK1/2 and Akt, a major target of PI3K. The mitogen-activated protein kinase kinase inhibitor 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (PD98059) prevented the quinpirole-evoked increase in ASP(+) accumulation, whereas inhibition of PI3K was without effect. Fluorescence flow cytometry and biotinylation studies revealed a rapid increase in DAT cell-surface expression in response to D2R stimulation. These experiments demonstrate that D2SR stimulation increases DAT cell surface expression and therefore enhances substrate clearance. Furthermore, they show that the increase in DAT function is ERK1/2-dependent but PI3K-independent. Our data also suggest the possibility of a direct physical interaction between DAT and D2R. Together, these results suggest a novel mechanism by which D2SR autoreceptors may regulate DAT in the central nervous system.
引用
收藏
页码:1222 / 1232
页数:11
相关论文
共 44 条
[11]   G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors [J].
Choi, EY ;
Jeong, DW ;
Park, KW ;
Baik, JH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (01) :33-40
[12]  
Costagliola S, 1998, J IMMUNOL, V160, P1458
[13]   Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum [J].
Dickinson, SD ;
Sabeti, J ;
Larson, GA ;
Giardina, K ;
Rubinstein, M ;
Kelly, MA ;
Grandy, DK ;
Low, MJ ;
Gerhardt, GA ;
Zahniser, NR .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) :148-156
[14]   Dopamine transporters are phosphorylated on N-terminal serines in rat striatum [J].
Foster, JD ;
Pananusorn, B ;
Vaughan, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :25178-25186
[15]  
Gomes I, 2003, METH MOLEC MED, V84, P157
[16]   Oligomerization of opioid receptors [J].
Gomes, I ;
Filipovska, J ;
Jordan, BA ;
Devi, LA .
METHODS, 2002, 27 (04) :358-365
[17]   N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization [J].
Grånäs, C ;
Ferrer, J ;
Loland, CJ ;
Javitch, JA ;
Gether, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (07) :4990-5000
[18]   The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer [J].
Guo, W ;
Shi, L ;
Javitch, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (07) :4385-4388
[19]   Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment [J].
Hastrup, H ;
Karlin, A ;
Javitch, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10055-10060
[20]  
Hersch SM, 1997, J COMP NEUROL, V388, P211